Catherine Toong

530 total citations
12 papers, 114 citations indexed

About

Catherine Toong is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, Catherine Toong has authored 12 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Genetics and 6 papers in Immunology. Recurrent topics in Catherine Toong's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Catherine Toong is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Catherine Toong collaborates with scholars based in Australia. Catherine Toong's co-authors include Stephen Adelstein, Tri Giang Phan, Susan J. Connor, Watson Ng, Roy G. Beran, Cecilia Cappelen‐Smith, Dennis Cordato, Rajesh Puranik, Min‐Xia Wang and Wei Xuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Gastroenterology and Hepatology and Journal of Crohn s and Colitis.

In The Last Decade

Catherine Toong

12 papers receiving 112 citations

Peers

Catherine Toong

IMMUN

GENET

EPIDE

RHEUM

RNMI

Abdullah Alsonbul Saudi Arabia

Amy Hemperly United States

Beata Gawdis-Wojnarska Germany

D. Chu Miow Lin France

Johanna Elin Gehin Norway

Pierre Philippet Belgium

Juliana Silva United Kingdom

Irit Tirosh Israel

Elisabeth Puchhammer Austria

Licínio Craveiro Switzerland

Abdullah Alsonbul Saudi Arabia

Catherine Toong

39 ×0.5

IMMUN

27 ×0.7

GENET

38 ×1.0

EPIDE

68 ×2.3

RHEUM

13 ×0.8

RNMI

Citations per year, relative to Catherine Toong Catherine Toong (= 1×) peers Abdullah Alsonbul

Countries citing papers authored by Catherine Toong

Since Specialization

Citations

This map shows the geographic impact of Catherine Toong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Toong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Toong more than expected).

Fields of papers citing papers by Catherine Toong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Toong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Toong. The network helps show where Catherine Toong may publish in the future.

Co-authorship network of co-authors of Catherine Toong

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Toong. A scholar is included among the top collaborators of Catherine Toong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Toong. Catherine Toong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Srinivasan, Ashish, et al.. (2023). Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses. Journal of Gastroenterology and Hepatology. 38(5). 724–732. 1 indexed citations

Toong, Catherine, et al.. (2022). Serum protein electrophoresis and rheumatoid factor analysis is an effective screening strategy for cryoglobulinaemia. Pathology. 55(3). 391–396. 7 indexed citations

Toong, Catherine, et al.. (2022). Serum protein electrophoresis and rheumatoid factor analysis as a screening strategy for cryoglobulinaemia. Pathology. 54. S82–S82. 1 indexed citations

Srinivasan, Ashish, et al.. (2022). P462 Upfront infliximab dose intensification for secondary loss of response in IBD: similar efficacy to dose interval shortening with the added advantage of early clinical and pharmacokinetic predictors of response. Journal of Crohn s and Colitis. 16(Supplement_1). i437–i438. 1 indexed citations

Connor, Susan J., et al.. (2020). Comparative Evaluation of 4 Commercially Available ELISA Kits for Measuring Adalimumab and Anti-adalimumab Antibodies. Therapeutic Drug Monitoring. 42(6). 821–828. 10 indexed citations

Toong, Catherine, et al.. (2020). Comparison of three commercially available ELISA assays for anti-infliximab antibodies. Pathology. 53(4). 508–514. 10 indexed citations

Lin, Brian L., et al.. (2019). Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost‐savings. Internal Medicine Journal. 51(5). 739–745. 14 indexed citations

Toong, Catherine, et al.. (2019). Monoclonal antibody interference in serum electrophoresis. Pathology. 51. S67–S67. 1 indexed citations

Connor, Susan J., et al.. (2016). Comparison of infliximab drug measurement across three commercially available ELISA kits. Pathology. 48(6). 608–612. 20 indexed citations

10.

Cappelen‐Smith, Cecilia, et al.. (2014). Anti-synthetase syndrome associated with anti PL-12 and anti-Signal recognition particle antibodies and a necrotizing auto-immune myositis. Journal of Clinical Neuroscience. 22(2). 396–398. 11 indexed citations

11.

Phan, Tri Giang, Catherine Toong, & Stephen Adelstein. (2011). Clearing the complexity: immune complexes and their treatment in lupus nephritis. SHILAP Revista de lepidopterología. 4. 17–17. 31 indexed citations

12.

Toong, Catherine, Rajesh Puranik, & Stephen Adelstein. (2010). Use of cardiac MR imaging to evaluate the presence of myocarditis in autoimmune myositis: three cases. Rheumatology International. 32(3). 779–782. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact